An interventional study of Modified eply & Semont maneuver and betahistine & Modified eply & Semont maneuver in Benign Paroxysmal Positional Vertigo, sponsored by Neuro Counsel Hospital, Pakistan. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-04-04.
Sponsored by Neuro Counsel Hospital, Pakistan · Not applicable, Interventional, and Treatment
: Benign Paroxysmal Positional Vertigo is a condition related to vestibular system accompanied by dizziness, tinnitus and balance problems leading to increased fall risk and potential disability. Various treatment options are available including pharmacotherapy and vestibular rehabilitation with varied results
Objective: The objective of this study was to compare the efficacy of Modified Epley \& Semont's maneuver with and without Betahistine for BPPV Material \& Methods: The study was a single blind randomized control trail. Total number of patients were 97 as calculated by Epitool calculator. Duration of the study was of one year from 2 January 2021 to 1st January 2022. Out of a total 97 patients, 90 met the inclusion criteria. These participants were randomized by lottery method into two equal groups. Group A (control group) was receiving both maneuvers only while group B (experimental group) included participants receiving betahistine along with both maneuvers. The impact of dizziness and quality of life was measured through EQ-5D-5L questionnaire and dizziness handicap inventory (DHI) in order to analyze the effectiveness of treatments. Pre and Post treatment results were compared within group by Wilcoxon rank test and for between groups, Mann Whitney U test was performed
248 studies on the registry are indexed under Vertigo; 39 are open to participants now.
This study's enrollment of 90 is above the median of 57 across 186 interventional studies indexed under Vertigo.
Browse Vertigo studies →Neuro Counsel Hospital, Pakistan is the lead sponsor of 11 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Control group
Other: Modified eply & Semont maneuver
experimental group
Other: betahistine & Modified eply & Semont maneuver
repositioning maneauvers
antihistamine plus repositioning maneuvers
Also known as: Modified eply & Semont maneuver
DHI
dizziness handicap inventery
Time frame: 1 month
EQ-5D-5L
quality of life
Time frame: 1 month
Plan to share: Undecided — we would share with other researcher so that they might be able to find study gaps
This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Neuro Counsel Hospital, Pakistan